Insider · CIK 0001827169
Barbara Ryan
Files at IVF (INVO Fertility, Inc.), INDV (Indivior Pharmaceuticals, Inc.), AZTR (Azitra, Inc.), INKT (MiNK Therapeutics, Inc.). First filing Jan 7, 2026, latest Mar 13, 2026.
Barbara Ryan files SEC Form 4 as director at INDV (Indivior Pharmaceuticals, Inc.), and also at INKT (MiNK Therapeutics, Inc.), IVF (INVO Fertility, Inc.), AZTR (Azitra, Inc.). Since Jan 7, 2026, Barbara Ryan has reported 3 open-market buys worth $29k and 2 open-market sells worth $27k, the latest filed on Mar 13, 2026.
A track record needs three past buys with six months of prices behind them; Barbara Ryan has 0, so none is measured yet.
The newest scored trade: bought $249 of INDV on Mar 13, 2026, filed Mar 13, 2026, scored 23 (weak). In the last 12 months: 3 buys worth $29k and 2 sells worth $27k.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
INDV: Indivior Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
INKT: MiNK Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Indivior Pharmaceuticals, Inc. | $249 8 shares | +0% | - | |
| 23Weak | Indivior Pharmaceuticals, Inc. | $1,009 31 shares | +1% | - | |
| 15Weak | INKTsell MiNK Therapeutics, Inc. | $22k 1,500 shares | -7% | - | |
| 15Weak | INKTsell MiNK Therapeutics, Inc. | $5,426 500 shares | -2% | - | |
| 30Weak | Indivior Pharmaceuticals, Inc. | $27k 775 shares | +65% | - |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,622 | $10.95 | $18k | 23,591 | 41 d ago |
| Mar 13, 2026 | INDV Indivior Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +8 | $31.09 | $249 | 5,724 | Mar 13, 2026 |
| Mar 9, 2026 | INDV Indivior Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +31 | $32.56 | $1,009 | 5,716 | Mar 11, 2026 |
| Mar 9, 2026 | INKT MiNK Therapeutics, Inc. | SOpen-market sale Common Stock | -200 | $10.17 | $2,035 | 21,706 | Mar 11, 2026 |
| Mar 10, 2026 | INKT MiNK Therapeutics, Inc. | SOpen-market sale Common Stock | -300 | $15.28 | $4,585 | 21,406 | Mar 11, 2026 |
| Mar 10, 2026 | INKT MiNK Therapeutics, Inc. | SOpen-market sale Common Stock | -500 | $15.57 | $7,783 | 20,906 | Mar 11, 2026 |
| Mar 10, 2026 | INKT MiNK Therapeutics, Inc. | SOpen-market sale Common Stock | -500 | $15.30 | $7,650 | 20,406 | Mar 11, 2026 |
| Feb 27, 2026 | INKT MiNK Therapeutics, Inc. | SOpen-market sale Common Stock | -400 | $10.86 | $4,343 | 22,006 | Mar 4, 2026 |
| Mar 2, 2026 | INKT MiNK Therapeutics, Inc. | SOpen-market sale Common Stock | -100 | $10.83 | $1,083 | 21,906 | Mar 4, 2026 |
| Jan 26, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Common Stock | +3,722 | $0.00 | $0 | 5,685 | Jan 28, 2026 |
| Jan 5, 2026 | INDV Indivior Pharmaceuticals, Inc. | POpen-market purchase Ordinary Shares10b5-1 | +775 | $35.39 | $27k | 1,963 | Jan 7, 2026 |
| Jan 2, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,395 | $0.00 | $0 | 5,395 | Jan 6, 2026 |
| Dec 19, 2025 | AZTR Azitra, Inc. | AGrant or award Stock Options (Right To Buy)derivative | +3,003 | $0.00 | $0 | 3,003 | Dec 22, 2025 |
| Dec 1, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,601 | $11.09 | $18k | 22,406 | Dec 3, 2025 |
| Sep 9, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,225 | $0.00 | $0 | 3,225 | Sep 11, 2025 |
| Sep 2, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,281 | $13.86 | $18k | 20,805 | Sep 3, 2025 |
| Aug 26, 2025 | IVF INVO Fertility, Inc. | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,157 | Aug 28, 2025 |
| Jun 2, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +2,476 | $7.17 | $18k | 19,524 | Jun 4, 2025 |
| Dec 1, 2024 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +24,229 | $0.73 | $18k | 150,336 | Dec 3, 2024 |
Questions about Barbara Ryan
Answered from the filings on this page, as of the latest one.
Is Barbara Ryan buying or selling?
In the last 12 months Barbara Ryan reported 3 open-market buys worth $29k and 2 open-market sells worth $27k on SEC Form 4; the latest was bought $249 of INDV on Mar 13, 2026. Grants, option exercises and tax withholding are not counted.
How did Barbara Ryan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Barbara Ryan has 0.
Where does Barbara Ryan file Form 4?
Barbara Ryan has filed Form 4 at INDV (Indivior Pharmaceuticals, Inc.); INKT (MiNK Therapeutics, Inc.); IVF (INVO Fertility, Inc.); AZTR (Azitra, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.